Psychiatric Drugs and Diabetes

Learning objectives for this Activity:

By the end of this module, you will be able to:
-List the impact of antipsychotic and antidepressant medications on development of metabolic syndrome, T2DM, DKA and GDM

Describe possible molecular mechanisms underlying development of dysglycemia associated with use of these drugs

Develop and treatment plans for management of for dysglycemia in patients for whom antipsychotic and/or antidepressant medications are being started

Sign in to access this activity